Effect of Remimazolam Co-induction and Maintenance on Postoperative Delirium In Older Patients Undergoing undergoing laparoscopic surgery: A Randomized Controlled Clinical Trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300076990

Enrollment

Unknown

Registered

2023-10-26

Start date

2023-10-31

Completion date

Unknown

Last updated

2023-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who underwent laparoscopic radical resection for colorectal cancer

Interventions

R Group:Anesthesia was induced and maintained by continuous intravenous pump injection of propofol remazolam.

P Group:Anesthesia was induced and maintained by continuous intravenous pump injection of propofol

Eligibility

Sex/Gender

All

Age

65 Years to 90 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients who underwent laparoscopic radical resection for colorectal cancer in our hospital from October 2023 to October 2024. 1. Age >= 65 years; 2. American Society of Anesthesiologists' (ASA) classification I-III; 3. Body Mass Index (BMI) 18-30 kg/m2.

Exclusion criteria

Exclusion criteria: Exclusion criteria: ? emergency operation; ? Allergic to benzodiazepines; ?Patients with a history of mental illness and long-term use of sedation, analgesia and antipsychotics; ? Major surgery in the last 2 years; ? Excessive alcohol consumption, severe visual and hearing impairment, or inability to complete the score measurement.

Design outcomes

Primary

Measure	Time frame
Incidence of delirium within 3 days after surgery;Cognitive function status;	—

Secondary

Measure	Time frame
VAS analgesia score;	—

Countries

China

Contacts

Public ContactJun Li

Dazhou Central Hospital

346667814@qq.com+86 138 8288 1868

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026